Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7219463
Reference Type
Journal Article
Title
Impact of preformulation on drug development
Author(s)
Bharate, SS; Vishwakarma, RA; ,
Year
2013
Is Peer Reviewed?
Yes
Journal
Expert Opinion on Drug Delivery
ISSN:
1742-5247
EISSN:
1744-7593
Volume
10
Issue
9
Page Numbers
1239-1257
Language
English
PMID
23534681
DOI
10.1517/17425247.2013.783563
Abstract
Preformulation assists scientists in screening lead candidates based on their physicochemical and biopharmaceutical properties. This data is useful for selection of new chemical entities (NCEs) for preclinical efficacy/toxicity studies which is a major section under investigational new drug application. A strong collaboration between discovery and formulation group is essential for selecting right NCEs in order to reduce attrition rate in the late stage development.
Keywords
Drug development; Investigational new drug; Preformulation; Product recall
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity